Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 92 | ETA2023 | Next issue

45th Annual Meeting of the European Thyroid Association (ETA) 2023

Poster Presentations

Case Reports 1

ea0092ps2-14-01 | Case Reports 1 | ETA2023

A case of congenital "hypothyroidism"

Yafi Michael

Introduction: Neonatal screening for congenital hypothyroidism is considered a major cornerstone in making early diagnosis and starting therapy in neonates. This is a very important step to prevent the consequences of untreated hypothyroidism including mental retardation and developmental delay. Neonatal screening is usually conducted by screening the level of T4 with or without TSH level. Confirming the diagnosis of hypothyroidism is a very important step before starting ther...

ea0092ps2-14-02 | Case Reports 1 | ETA2023

Thyrotoxicosis in a patient with turner syndrome: radioactive iodine therapy

Guseinova Raisat , Korchagina Maria , Trukhin Alexey , Sheremeta Marina

Introduction: Turner syndrome (TS) is a chromosomal disorder affecting female and characterized by complete or partial monosomy of the X chromosome. These genetic changes lead to the abnormalities in growth and development and increase the risk of autoimmune diseases, including those affecting the thyroid. Thyroid pathology in TS may include autoimmune thyroiditis, hypothyroidism, thyrotoxicosis (Graves disease, AIT in the hyperthyroid state). Thyrotoxicosis is the clinical sy...

ea0092ps2-14-03 | Case Reports 1 | ETA2023

Two cases of radioactive iodine refractory malignant struma ovarii with nras mutation

Yoo Jungmin , Kim ChaeA , Yong Kim Tae , Bae Kim Won , Eun Song Dong , Gu Kim Won

Background: Struma ovarii is a germ cell tumor of the ovary containing ≥ 50% thyroid tissue and malignant struma ovarii (MSO) is a very rare disease containing papillary or follicular thyroid carcinomas (FTC). There is no consensus on optimal management for patients with MSO and no data on radioactive iodine (RAI) responsiveness. Here, we report two cases with RAI refractory MSO with NRAS mutation detected by next-generation sequencing (NGS). Case ...

ea0092ps2-14-04 | Case Reports 1 | ETA2023

Diagnosis and management of a thyrotoxicosis storm on unknown hyperthyroidism

Hanane Brahimi , Bouchenna Amira , Somia Fetouci , Ouldkablia Samia

Introduction: In the spectrum of endocrine emergencies, thyroid storm is one of the most critical complications. Recognition and appropriate management of life-threatening thyrotoxicosis is vital to prevent the high morbidity and mortality that may accompany this disorder. The incidence of thyroid storm has been noted to be less than 10% of patients hospitalized for thyrotoxicosis; however, the mortality rate secondary to thyroid storm ranges from 20 to 30%. We report in this ...

ea0092ps2-14-05 | Case Reports 1 | ETA2023

28 years of thyroid eye disease reactivations

Schovanek Jan , Karhanova Marta

A male patient, currently 64 years old, was diagnosed with TED (Thyroid Eye Disease) in 1993 when he underwent surgery for “exophthalmos” in both eyes (likely decompression surgery), followed by surgery to correct diplopia. He underwent a total thyroidectomy one year later. For ongoing “activity” of thyroid and TED patient received radioiodine ablation in 1995 and 1997. At that time, he also received “some pulses” of methylprednisolone and long-te...

ea0092ps2-14-06 | Case Reports 1 | ETA2023

Amyloid goiter in patient with mediteranian fever

Karapetyan Meri , Varzhapetyan Armen

Introduction: The thyroid gland is affected by amyloidosis in 50% of cases in primary amyloidosis and80% in secondary amyloidosis.Case report: The patient, male, born in 1976 was admitted to the department of endocin Surguary of the Astghik Medical Center, Armenia complaining of general weakness, feeling of compression and heaviness in the neck (cervical discomfort), cough, shortness of breath, swallowing difficulty. When the patient was 12 years old dia...

ea0092ps2-14-07 | Case Reports 1 | ETA2023

Primary thyroid mucoepidermoid carcinoma with extensive pulmonary metastasis

Sirbu Anca , Martin Sorina , Terzea Dana , Voda Claudia , Burga Alexandra , Fica Simona

Mucoepidermoid carcinomas (MECs) are the most common malignant tumors of the salivary glands. Primary thyroid MECs are extremely rare (about 0.5% of all thyroid malignancies) and, in the majority of cases, are associated with an indolent biologic potential and excellent long-term prognosis. We present the case of a 67-year-old man, with a recently growing anterior cervical mass, associating dyspnoea and fatigue. Thyroid ultrasound revealed an inhomogeneous, hypoechoic mass in ...

ea0092ps2-14-08 | Case Reports 1 | ETA2023

Thyrotoxic periodic paralysis: report of two cases

Triantafilo Schilling Yasson , Romero Quintanilla Katerine , Hernandez Munoz Hilda , Avila Osores Catalina , Avila Daniela

Introduction: Hypokalemic periodic paralysis (HPP) belongs to a group of inherited diseases called channelopathies, whose main manifestation include painless muscle paralysis. There are also acquired forms of HPP secondary to hyperthyroidism, called thyrotoxic periodic paralysis (TPP). It’s prevalence is markedly higher in men.Case Reports: Case 1. 34-year-old Venenzuelan man, without medical history. He consults in the emergency de...

ea0092ps2-14-09 | Case Reports 1 | ETA2023

Lowering of circulating thyroxine levels in graves’ disease resulting in rhabdomyolysis: A less known complication in management of graves’ disease

Sonawane Vikram

Thyrotoxicosis causing hypokalaemic paralysis is a known complication among Asians, Myopathy as a result of thyrotoxicosis or caused by antithyroid drugs (ATD) is rare. Myositis, resulting in a rise in creatinine kinase levels (CK) is commonly seen in overt hypothyroidism, however, rapid lowering in circulating thyroid hormone levels during the treatment of Graves’ disease could result in myalgia and elevated CK levels. This complication needs to be actively diagnosed whe...